Yijun LIU, Shuliang ZHAN. The progress of activator protein-1 and glioma. Med Recapitulate. 2006;17:1050–2.

Google Scholar 

Junkai XIA, Jie SONG, Xuemei WEN, et al. Roles of AP-1 in malignant tumor. Chem Life. 2022;42(12):2141–7.

Google Scholar 

Song D, Lian Y, Zhang L. The potential of activator protein 1 (AP-1) in cancer targeted therapy. Front Immunol. 2023;6(14):1224892.

Article  Google Scholar 

Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci. 2004;117(Pt 25):5965–73.

Article  CAS  PubMed  Google Scholar 

Junhui L, Wunai Z, Yan Z, et al. MKK7/JNKs/c-Jun pathwaypromotes perineural invasion through promoting dedifferentiation of Schwann cells in pancreatic cancer. J Shanxi Med Univ. 2022;53(06):77–684.

Google Scholar 

Xiaolong FAN, Qiuxia HOU, Taohong LUO, et al. Research progress of Jun transcription factor family and hepatocellular carcinoma. China Med Pharm. 2023;13(05):49–52.

Google Scholar 

Miyake T, McDermott JC. Nucleolar localization of c-Jun. FEBS J. 2022;289(3):748–65.

Article  CAS  PubMed  Google Scholar 

Casalino L, Talotta F, Matino I, Verde P. FRA-1 as a regulator of EMT and metastasis in breast cancer. Int J Mol Sci. 2023;24(9):8307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakiri L, Macho-Maschler S, Custic I, et al. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. Cell Death Differ. 2015;22(2):336–50.

Article  CAS  PubMed  Google Scholar 

Talotta F, Casalino L, Verde P. The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications’ door. Oncogene. 2020;39:4491–506.

Article  CAS  PubMed  Google Scholar 

Schnoegl D, Hiesinger A, Huntington ND, Gotthardt D. AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity. Curr Opin Immunol. 2023;85:102397.

Article  CAS  PubMed  Google Scholar 

Laura C, Francesco T, Ilenia M, et al. FRA-1 as a regulator of EMT and metastasis in breast cancer. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms24098307.

Article  PubMed  PubMed Central  Google Scholar 

Nannan MA, Xianling GUO, Jin WANG, et al. The role of AP-1 in the upregulation of the multidrug resistance gene MDR1 in a drug-resistant gastric carcinoma cell line. Chin J Clin Oncol. 2008;10:582–6.

Google Scholar 

Jiang X, Xie H, Dou Y, et al. Expression and function of FRA1 protein in tumors. Mol Biol Rep. 2020;47(1):737–52.

Article  CAS  PubMed  Google Scholar 

Young MR, Colburn NH. Fra-1 a target for cancer prevention or intervention. Gene. 2006;1(379):1–11.

Article  Google Scholar 

Zanconato F, Forcato M, Battilana G, et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015;17(9):1218–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang ZQ, Liang J, Schellander K, et al. c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Res. 1995;55(24):6244–51.

CAS  PubMed  Google Scholar 

Zhang Y, Narayanan SP, Mannan R, et al. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci USA. 2021;118(24):e2103240118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng J, Liu F, Su C. Unveiling the hidden AP-1: revealing the crucial role of AP-1 in ccRCC at single-cell resolution. Mol Cancer. 2023;22(1):209.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meinsohn MC, Smith OE, Bertolin K, Murphy BD. The orphan nuclear receptors steroidogenic factor-1 and liver receptor homolog-1: structure, regulation, and essential roles in mammalian reproduction. Physiol Rev. 2019;99(2):1249–79.

Article  CAS  PubMed  Google Scholar 

Dubé C, Bergeron F, Vaillant MJ, et al. The nuclear receptors SF1 and LRH1 are expressed in endometrial cancer cells and regulate steroidogenic gene transcription by cooperating with AP-1 factors. Cancer Lett. 2009;275(1):127–38.

Article  PubMed  Google Scholar 

Elangovan IM, Vaz M, Tamatam CR, et al. FOSL1 promotes kras-induced lung cancer through amphiregulin and cell survival gene regulation. Am J Respir Cell Mol Biol. 2018;58(5):625–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riedel M, Cai H, Stoltze IC, Vendelbo MH, et al. Targeting AP-1 transcription factors by CRISPR in the prostate. Oncotarget. 2021;12(19):1956–61.

Article  PubMed  PubMed Central  Google Scholar 

Muhammad N, Bhattacharya S, Steele R, et al. Involvement of c-Fos in the promotion of cancer stem-like cell properties in head and neck squamous cell carcinoma. Clin Cancer Res. 2017;23(12):3120–8.

Article  CAS  PubMed  Google Scholar 

Cai J, Huang F, Gao W, et al. Androgen receptor/AP-1 activates UGT2B15 transcription to promote esophageal squamous cell carcinoma invasion. Cancers. 2023;15(24):5719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Liu Q, Zheng S, et al. MicroRNA-21 promotes cell growth and migration by targeting programmed cell death 4 gene in Kazakh’s esophageal squamous cell carcinoma. Dis Markers. 2014;2014:232837.

Article  PubMed  PubMed Central  Google Scholar 

Jingrong YANG, Jian WU, Shixin YE, et al. Effect of miR-21/PDCD4/AP-1 on proliferation, invasion and migration of esophageal cancer cells. China Medical Herald. 2020;17(20):4–9.

Google Scholar 

Zhuo B, Zhang Q, Xie T, et al. Integrative epigenetic analysis reveals AP-1 promotes activation of tumor-infiltrating regulatory T cells in HCC. Cell Mol Life Sci. 2023;80(4):103.

Article  CAS  PubMed  PubMed Central  Google Scholar 

ZHUO B W. Integrative Epigenetic Analysis Reveals AP-1 Promotes Activation of Tumor-infiltrating Regulatory T Cells [D]. Southern Medical University, 2023.

Trop-Steinberg S, Azar Y. AP-1 expression and its clinical relevance in immune disorders and cancer. Am J Med Sci. 2017;353(5):474–83.

Article  PubMed  Google Scholar 

Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg. 1995;221(6):706–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He H, Sinha I, Fan R, et al. c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer. Oncogene. 2018;37(19):2586–600.

Article  CAS  PubMed  Google Scholar 

ZHAO Q. Relation between AP-1 and Triple Negative Breast Cancer and Effect of an AP-1-Selective Inhibitor T5224 on Triple Negative Breast Cancer Cells [D]. Jilin University, 2021.

Bièche I, Lerebours F, Tozlu S, et al. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res. 2004;10(20):6789–95.

Article  PubMed  Google Scholar 

Arnold L, Gomez JP, Barry M, et al. Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression. Explor Target Antitumor Ther. 2023;4(5):1104–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurt Yilmaz N, Schiffer CA. Introduction: drug resistance. Chem Rev. 2021;121(6):3235–7.

Article  CAS  PubMed